Somatic mutation profile of breast cancer in Uganda

iCCaRE Consortium for Black Men: Second Discussion

Primary mediastinal B-cell lymphoma: Radiotherapy superfluous post-chemoimmunotherapy

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma

Talazoparib plus enzalutamide shows improvement in PFS over standard of care in firstline HRR mCRPC

Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis

Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder cancer

Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer

2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer

ASCO 2023: Breast cancer research highlights

Ciltacabtagene autoleucel greatly reduces risk of disease progression in lenalidomide-refractory MM

mRCC: Atezolizumab after progression with prior ICI treatment shows no benefit and increases toxicity